1. Home
  2. A vs VTR Comparison

A vs VTR Comparison

Compare A & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$114.94

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Logo Ventas Inc.

VTR

Ventas Inc.

HOLD

Current Price

$88.25

Market Cap

42.6B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
A
VTR
Founded
1999
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
39.8B
42.6B
IPO Year
1999
2005

Fundamental Metrics

Financial Performance
Metric
A
VTR
Price
$114.94
$88.25
Analyst Decision
Strong Buy
Buy
Analyst Count
15
13
Target Price
$161.47
$87.62
AVG Volume (30 Days)
1.9M
4.7M
Earning Date
05-27-2026
04-27-2026
Dividend Yield
0.92%
2.38%
EPS Growth
3.16
184.21
EPS
1.07
0.11
Revenue
$4,472,000,000.00
$5,833,980,000.00
Revenue This Year
$8.45
$14.00
Revenue Next Year
$6.13
$8.35
P/E Ratio
$107.22
$799.50
Revenue Growth
6.43
18.47
52 Week Low
$108.35
$61.76
52 Week High
$160.27
$91.06

Technical Indicators

Market Signals
Indicator
A
VTR
Relative Strength Index (RSI) 50.35 56.14
Support Level $110.10 $84.56
Resistance Level $116.40 $91.06
Average True Range (ATR) 3.37 1.81
MACD 0.12 -0.09
Stochastic Oscillator 53.81 52.46

Price Performance

Historical Comparison
A
VTR

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Share on Social Networks: